Rapporten
Dybdegående analyser af virksomhedsfinansiering, vækststrategier og markedsindsigt fra verdens mest innovative virksomheder
2 rapporter og tæller
Opdateret dagligt med den seneste markedsintelligens
Fundraising
Lyell Immunopharma
Lyell Immunopharma Raises $425M in Series C
Lyell Immunopharma, a Biotech company based in 201 Haskins Way, South San Francisco, CA 94080, has raised $425M in Series C at a $1.4B valuation led by GV, F-Prime Capital, Bain Capital Life Sciences, Patient Square Capital, Bristol Myers Squibb.
Fundraising News Team
Mar 9, 2024
0 min read
Biotech
Lyell Immunopharma
Lyell Immunopharma raises $425M Series C at $1.4B valuation
Lyell Immunopharma raises $425M in Series C at $1.4B valuation. T-cell reprogramming for solid tumors...
Editorial Team
Mar 9, 2024
0 min read•$425M
Side 1
Viser 2 rapporter • Side 1 • Kategori: all
Hold dig foran markedet
Få ugentlig indsigt leveret til din indbakke. Ingen spam, kun intelligens.